CAR T Cells in Patients With MMP2+ Recurrent or Progressive Glioblastoma
Clinical trial NCT05627323 · TERMINATED
Trial details
- NCT number
- NCT05627323
- Sponsor
- Chimeric Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-06
- Primary completion
- 2026-04-30
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.